BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37422351)

  • 1. Survival After Cryotherapy Versus Radiotherapy in Low and Intermediate Risk Localized Prostate Cancer.
    Li H; Xu Z; Lv Z; Wang M; Liu M
    Clin Genitourin Cancer; 2023 Dec; 21(6):679-693. PubMed ID: 37422351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer.
    Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Hoeh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
    Prostate; 2022 May; 82(6):740-750. PubMed ID: 35226380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer.
    Miao Q; Wei Z; Liu C; Ye Y; Cheng G; Song Z; Chen K; Zhang Y; Chen J; Yue C; Ruan H; Zhang X
    Front Oncol; 2023; 13():1130680. PubMed ID: 37207146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryotherapy shows no inferiority compared with radical Prostatectomy for low-risk and intermediate-risk localized Prostate Cancer: a real-world study from the SEER database.
    Jin K; Qiu S; Zheng X; Li Y; Zhang S; Li J; Liao X; Tu X; Yang L; Wei Q
    J Cancer; 2020; 11(19):5738-5745. PubMed ID: 32913467
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
    Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
    Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of survival between active surveillance or watchful waiting and focal therapy for low-risk prostate cancer: a real-world study from the SEER database.
    Yuan QM; Lin TH; Jin K; Qiu S; Zhou XH; Jin D; Li JK; Yang L; Wei Q
    Asian J Androl; 2022; 24(3):305-310. PubMed ID: 34596600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
    Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
    Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study.
    Gandaglia G; Karakiewicz PI; Briganti A; Trinh QD; Schiffmann J; Tian Z; Kim SP; Nguyen PL; Graefen M; Montorsi F; Sun M; Abdollah F
    Ann Oncol; 2014 May; 25(5):979-86. PubMed ID: 24562445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing effectiveness of radical prostatectomy versus external beam radiotherapy in patients with locally advanced prostate cancer: A population-based analysis.
    Zhou X; Jin K; Qiu S; Jin D; Liao X; Tu X; Zheng X; Li J; Yang L; Wei Q
    Medicine (Baltimore); 2020 Aug; 99(34):e21642. PubMed ID: 32846773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate-term oncological and functional outcomes of salvage cryotherapy for the management of prostate cancer recurrence after primary brachytherapy versus primary cryotherapy: A propensity score-matched analysis.
    Deivasigamani S; Orabi H; El-Shafei A; Adams ES; Kotamarti S; Aminsharifi A; Davis L; Wu Y; J SJ; Polascik TJ
    Prostate; 2023 Oct; 83(14):1373-1386. PubMed ID: 37469120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Outcomes for Metastatic Prostate Cancer Patients Treated With Radical Prostatectomy or Radiation Therapy: A SEER-based Study.
    Jin K; Qiu S; Jin H; Zheng X; Zhou X; Jin D; Li J; Yang L; Wei Q
    Clin Genitourin Cancer; 2020 Dec; 18(6):e705-e722. PubMed ID: 32763123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucinous Prostate Cancer Shows Similar Prognosis to Typical Prostate Acinar Carcinoma: A Large Population-Based and Propensity Score-Matched Study.
    Zhao F; Yu X; Xu M; Ye S; Zang S; Zhong W; Ren G; Chen X; Yan S
    Front Oncol; 2019; 9():1467. PubMed ID: 31998638
    [No Abstract]   [Full Text] [Related]  

  • 15. How to choose proper local treatment in men aged ≥75 years with cT2 localized prostate cancer?
    Jin K; Qiu S; Li J; Zheng X; Tu X; Liao X; Yang Y; Yang L; Wei Q
    Cancer Med; 2019 Jul; 8(7):3370-3378. PubMed ID: 31066510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Radiotherapy versus Focal Laser Ablation in Patients with Low and Intermediate Risk Localized Prostate Cancer.
    Zhou X; Jin K; Qiu S; Jin D; Liao X; Tu X; Zheng X; Li J; Yang L; Wei Q
    Sci Rep; 2020 Jun; 10(1):9112. PubMed ID: 32499484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Therapy Improves Survival in Metastatic Prostate Cancer.
    Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Steuber T; Huland H; Graefen M; Karakiewicz PI
    Eur Urol; 2017 Jul; 72(1):118-124. PubMed ID: 28385454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study.
    Abdollah F; Sun M; Schmitges J; Thuret R; Tian Z; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):95-103. PubMed ID: 22330991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate.
    Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Höh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
    Int Urol Nephrol; 2022 Jan; 54(1):89-95. PubMed ID: 34797483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal Laser Ablation Versus Radical Prostatectomy for Localized Prostate Cancer: Survival Outcomes From a Matched Cohort.
    Zheng X; Jin K; Qiu S; Han X; Liao X; Yang L; Wei Q
    Clin Genitourin Cancer; 2019 Dec; 17(6):464-469.e3. PubMed ID: 31594734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.